Open Access

Acetyl and butyryl cholinesterase inhibitory sesquiterpene lactones from Amberboa ramosa

  • Muhammad Ibrahim1Email author,
  • Tahir Farooq1,
  • Nusrat Hussain2,
  • Amjad Hussain2,
  • Tahsin Gulzar1,
  • Iqbal Hussain3,
  • Muhammad Sajid Hamid Akash4 and
  • Fouzia Sultana Rehmani5
Chemistry Central Journal20137:116

https://doi.org/10.1186/1752-153X-7-116

Received: 6 March 2013

Accepted: 19 June 2013

Published: 10 July 2013

Abstract

Background

Alzheimer’s disease (AD) is characterized by a progressive memory loss that leads to a profound emotional disturbance in later stages. As no safe and effective drug is yet available for the treatment of AD, secondary metabolites from plants may be instrumental in meeting this challenge. Keeping in view this point we evaluated sesquiterpenes of medicinal plant Amberboa ramosa for their cholinesterase inhibitory activity.

Results

Four sesquiterpene lactones have been isolated from the ethyl acetate soluble fraction of Amberboa ramosa. In which one compound Amberbin C (1) was found to be new while other three Amberin (2), Amberbin A (3), and Amberbin B (4) were previously reported ones. The structures of the isolated compounds were elucidated using different spectroscopic techniques. Isolated compounds were tested for their inhibitory potential against acetyl cholinesterase and butyryl cholinesterase enzymes. All compounds showed excellent inhibitory activities against acetyl cholinesterase and butyryl cholinesterase.

Conclusions

A new sesquiterpene lactone has been isolated and fully characterized, the sesquiterpene lactones from Amberboa ramosa showed good inhibitory activities against acetyl cholinesterase and butyryl cholinesterase enzymes, this study indicated that sesquiterpene lactone can become interesting lead molecules in drug development against Alzheimer’s disease (AD).

Keywords

Amberbin C Amberboa ramosa CompositeaeAcetyl cholinesteraseButyryl cholinesterase

Background

Cholinesterases (ChE) form an important class of enzymes intimately connected with the nervous system. Acetylcholine (ACh) was first synthesized in 1867. In 1906 it was detected in the adrenal gland of human tissue as a neurotransmitter, which transmits signals from one nerve cell to another. Cholinesterases ChE inactivate acetylcholine by hydrolyzing it into choline and acetic acid. Cholinesterase inhibitor increases the availability of ACh for nerve cell communications [1]. Alzheimer’s disease (AD) is characterized by a progressive memory loss that leads to a profound emotional disturbance in later stages. The disease is accompanied by dysfunctions in cholinergic neurotransmission of the central nervous system [2]. Hence, cholinesterase inhibitors may act as potential leads in the discovery of therapeutics for such nervous system disorders.

As the anti cholinesterase activity of chloroform soluble fraction from Amberboa ramosa has previously been reported [3], keeping in view this point we evaluated the guaianolides (sesquiterpenes) isolated from chloroform soluble fraction of Amberboa ramosa for their cholinesterase inhibitory activity. The genus Amberboa belongs to the family Compositeae and comprises of six species. Amberboa ramosa is an annual herb which belongs to genus Amberboa and family Compositeae. It is mainly found in Pakistan and India. Amberboa ramosa has tonic, aperient, febrifuge, deobstruent, cytotoxic and antibacterial activities [4]. Literature survey revealed that triterpenoids, flavonoids, steroids and sesquiterpene lactones have previously been reported from this species [4, 5]. In this study we have isolated four guaianolides (sesquiterpenes) out of which Amberbin C (1) was identified as a new compound while other three Amberin (2) [6], Amberbin A (3) and Amberbin B (4) [7] were previously been reported from the same source. All structures were elucidated by using different spectroscopic techniques like UV, IR, EI-MS, 1D and 2D NMR techniques.

Results and discussion

Amberbin C (Figure 1) was isolated as colorless crystals with [α]20 D +51 (c = 0.02, CHCl3) and mp 141–142°C. The HR-EI-MS exhibited a [M+] peak at m/z 382.1997 corresponding to the molecular formula C20H30O7 (calcd. for C20H30O7; 382.1992), which indicated six degrees of unsaturation. Further prominent peaks at m/z 364.2, 308.2, 339.2 and 324.2 represented the losses of [MH2O]+, [M-C3H6O2] + and [M-COCH3-CH3]+, respectively (Figure 1).
Figure 1

Structures of compounds 1–4.

The IR spectrum showed characteristic absorption bands for γ-lactone and ester groups at 3410 (OH), 1750 (lactone), 1730 (ester) and 1655 (C = C), respectively. In the UV spectrum moderate absorption bands between 196–202 nm further indicated the presence of γ-lactone moiety [8]. Further spectral data showed close agreement with a guaianolide type sesquiterpene [911]. The 1H-NMR spectrums showed signals for a trisubstituted double bond at δ 5.40. It also showed signals for the oxymethine protons at δ 5.07 (ddd, J = 8.3, 6.0, 5.5 Hz) and 4.25 (dd, J = 10.0, 8.3 Hz) (see Table 1). The latter was assigned to the proton geminal to the lactone oxygen atom [12]. It showed 1H-1H correlations to the vicinal protons at δ 2.90 (dd, J = 9.0, 8.8 Hz) and δ 2.85 (ddd, J = 10.0, 9.5, 8.3 Hz) which could subsequently be assigned to H-5 and H-7, respectively. The larger coupling constants suggested trans-diaxial disposition among H-5, H-6 (β) and H-7, providing conclusive evidence for an α orientation of both H-5 and H-7. The coupling pattern of the proton signals for H-1 and H-9 supported the guaianolide structure [13]. The entire sequence of protons attached to the guaianolide skeleton was established by correlation spectroscopy (COSY) and spin decoupling experiments (Figure 2). Irradiation of the H-5 proton at δ 2.90 simplified the double doublet of H-6 at δ 4.25 into a double and the doublet of double doublets of H-1 into a doublet doublet. Irradiation of H-7 proton at δ 2.85 simplified the doublet of quartet at δ 2.50 into a quartet. Irradiation of H-11 proton at δ 2.50 simplified the doublet of the methyl group at δ 1.24 into a singlet confirming the presence of a methyl group at C-11. Irradiation of H-3 at δ 5.40 turned the double doublets at δ 2.24 (H-2α) and 2.35 (H-2β) into doublets. The signal at 1.79 could be assigned to methyl protons at C-15 and further confirmed by 2 J and 3 J correlations with C-4 (δ 144.0), C-3 (δ 126.8) and C-5 (δ 55.0). The O-acetyl group was assigned to C-8, on the basis of strong HMBC correlation between oxymethine proton of C-8 at δ 5.07 and the carbonyl carbon at δ 181.0 as shown in Figure 2. The glycerol moiety could be assigned to C-10 based on its lower frequency shift compared to unsubstituted guaianolides [7], and supported by HMBC correlations between oxymethine proton of C-18 at δ 3.64 and C-10 at δ 81.1 (Figure 2). The signals at δ 3.59 (2H), 3.48 (2H) were assigned to four diastereomeric protons of glycerol moiety. These protons showed COSY and HMBC correlations with H-18 (δ 3.64) and C-18 (δ 73.9) (Figure 2). It further confirmed the presence of glycerol moiety. The 13C-NMR spectrum (Broad band and DEPT) showed signals for 20 carbons comprising of four methyls, four methylene, eight methine and four quaternary carbons. The low frequency region showed four signals at δ 181.0, 172.1, 144.0 and 126.8, which could be assigned to O-acetyl, lactone ester and trisubstituted olefinic carbons. One oxygenated quaternary and two oxygenated methine carbons resonated at δ 81.1, 75.4 and 82.3 respectively. The position of substituents was confirmed by HMQC, HMBC and COSY experiments.
Table 1

1 H- and 13 C-NMR for compound 68; CD 3 OD soln.; δ in ppm, J in Hz

Position

δ(H)a)

δ(C)b)

Multiplicity

1

2.80 ddd (9.0, 8.5, 8.0)

53.0

CH

2

2.35 dd (15.5, 5.0)

34.0

CH2

2.24 dd (9.0, 8.0)

3

5.40 brd s

126.8

CH

4

-

144.0

C

5

2.90 dd (9.0, 8.8)

55.0

CH

6

4.25 dd (10.0, 8.3)

82.3

CH

7

2.85 ddd (10.0, 9.5, 8.3)

52.3

CH

8

5.07 ddd (8.3, 6.0, 5.5)

75.4

CH

9

1.86 dd (12.3, 5.5)

42.8

CH2

2.38 dd (12.3, 6.0)

10

-

81.1

C

11

2.50 dq (11.0, 5.8)

42.1

CH

12

-

172.1

C

13

1.24 d (6.9)

15.7

CH3

14

1.27 s

26.1

CH3

15

1.79 s

17.7

CH3

16

-

181.0

C

17

2.05 s

21.3

CH3

18

3.63-3.65 m

73.86

CH

19

3.59 d

64.4

CH2

3.56 d

20

3.52 d

64.4

CH2

3.48 d

a) Recorded at 400 MHz; b) Recorded at 100 MHz.

Figure 2

Important COSY and HMBC correlations.

Figure 3

Important NOESY correlations.

The relative stereochemistry at various chiral centers of amberbin C (1) were assigned through NOESY experiments (Figure 3), which revealed trans/anti/cis-fusion of the α-methyl-γ-lactone moity, the seven member ring at C-7 and C-6, the five member ring at C-5 and C-1 [1416]. The cis-fusion of guaianoloid is also proven by the strong correlation between the H-1 at δ 2.80 and H-5 at δ 2.90. The α-orientation of the acetate group at C-8 could also be deduced through strong interaction in NOESY experiment between the oxymethine proton attached to C-8 resonating at δ 5.07 and H-6 at δ 4.25. Thus, the structure of amberin C (1) could be assigned as 8α-Acetoxy-10α-(1, 3-dihydroxy-2-propyl)-1 α H, 5α H, 6β H, 7α H, 11 β H, 11α-methylguaia-3-enolide.

Biological evaluation

The Compound (1) and (2) showed good inhibitory potential towards acetyl cholinesterase. Compound (2) also showed potent activity against butyryl cholinesterase. Compound (3), and (4) showed significant activity against acetyl cholinesterase and potent activity against butyryl cholinesterase (see Table 2). Compound (1) also showed moderate butyryl cholinesterase inhibitory activity. All four compounds share similar basic skeleton, they differ only due to the substituents present at C-8 and C-10. Compound 3 which have O-acetyl group at C-8 and OH group at C-10 showed moderate inhibitory potential towards both cholinestrease enzymes. Compound 4 only differs from Compound 3 due to the presence of an α-D-glucose group at C-10, the introduction of glucose moeity significantly increases the cholinestrease inhibitory activity. While in case of compound 2 which have glucose moeity at C-8 and O-acetyl at C-10 a significant decrease in acetylcholinestrease inhibitory activity occures, while butrylcholinestrease inhibitory activity was almost the same. Simillarly in case of compound 1 which have glycerol moeity at C-10 significant anti-acetylcholinestrease activity was observed. On the basis of these results we can conclude that the effect of substituents at C-10 is more important towards acetylcholinestrease enzyme, mostly activity enhances with the presence of substituents.
Table 2

In vitro anticholinesterase activities of compounds 1–4

 

IC 50 (μM) ± SEMa

 

S. No

Compounds

AChE

BChE

1

Amberbin C (1)

1.1 ± 0.08

17.9 ± 0.05

2

Amberin (2)

17.5 ± 0.01

2.7 ± 0.02

3

Amberbin A (3)

8.6 ± 0.15

4.8 ± 0.15

4

Amberbin B (4)

0.91 ± 0.015

2.5 ± 0.15

5

Galanthamineb

0.5 ± 0.01

8.2 ± 0.02

6

Eserineb

0.04 ± 0.0001

0.82 ± 0.001

a Standard error of the mean of five assays; b positive control used in the assays.

Conclusions

A new sesquiterpene lactone has been isolated and fully characterized, the sesquiterpene lactones from Amberboa ramosa showed good inhibitory activities against acetyl cholinesterase and butyryl cholinesterase enzymes, this study indicated that sesquiterpene lactone can become interesting lead molecules in drug development against Alzheimer’s disease (AD).

Experimental

General experimental procedures

Melting points were determined on a Gallenkemp apparatus and are uncorrected. IR spectra were measured on a JASCO 302-A spectrophotometer with KBr cells. UV spectra were obtained on a Hitachi UV-3200 spectrophotometer. Optical rotations were measured on a JASCO DIP-360 polarimeter and the 1D and 2D NMR spectra were recorded on a Bruker AMX-400 Spectrometer operating at 400 MHz for 1H and 100 MHz for 13C. Electron impact (EI) mass spectra were recorded on JEOL JMS-HX-110 and Varian MAT-311-A mass spectrometers. The HR-ESI-MS was recorded on a Jeol JMS 600H instrument. Silica gel (230–400 mesh, E. Merck, Darmstadt, Germany) was used for column chromatography. All reagents were obtained from Sigma Aldrich Chemical sand used without further purification. The redistilled and de-ion-ized water was used in all experiments. The spectrophotometer, Spectra max 384 from molecular devices USA is used for inhibition protocol.

Plant material

The whole plant of Amberboa ramosa Jafri (Compositae) was collected in June 2002, from Malir district of Karachi (Pakistan) and identified by Dr. Surraiya Khatoon, Plant Taxonomist, Department of Botany, University of Karachi, where a voucher specimen (no. KU 312 b) has been deposited.

Extraction and isolation

The shade dried plant material (8 kg) was extracted three times with methanol at room temperature. Solvents were evaporated through vacuum distillation. The condensed and crude methanolic extract (217 g) was partitioned between n-hexane and water. The water soluble fraction was further fractionated into chloroform, ethyl acetate and n-butanol soluble fraction. The column chromatography of the EtOAc soluble sub-fraction (90 g) over silica gel, using a mixture of n-hexane/EtOAc (collecting 200 ml for each), afforded six major fractions A (n-hexane: EtOAc 8:2), B (n-hexane: EtOAc 6.5:3.5), C (n-hexane: EtOAc 5.5:4.5) D (n-hexane: EtOAc 4:6), E (n-hexane: EtOAc 3:7) and Fraction F (100% EtOAc).

Sub-fraction A: It was subjected to vacuum liquid chromatography (VLC) using the solvent gradient from n-hexane- EtOAc to afford two sub-fractions AA and AB. The sub-fraction AA obtained from n-hexane-EtOAc (8:2) was further purified by column chromatography over silica gel eluting with n-hexane-EtOAc (8.5:1.5) to furnish compound 3 (13.5 mg).

Sub-fraction E: It was subjected to column chromatography over silica gel using mixtures of n-hexane-EtOAc (3:7) as eluent to obtain two major sub-fractions EA - EB. The sub-fraction EA was subjected to further column chromatography over silica gel eluting with n-hexane- EtOAc (3.5:6.5) as eluent to give compound 1 (11 mg), and n-hexane- EtOAc (4:6) to give compound 2 (7.8 mg). The sub-fraction EB was subjected to successive column chromatography over silica gel eluting with n-hexane- EtOAc (3.2:6.8) solvent system to yield compound 4 (9.4 mg).

Enzyme inhibitory assays

In vitro cholinesterase inhibition assay and determination of IC 50 Acetylcholinesterase (electric eel EC 3.1.1.7), butyrylcholinesterase (horse serum E.C. 3.1.1.8), acetylthiocholine iodide, butyrylthiocholine chloride, 5, 5′-dithiobis [2-nitrobenzoic-acid] (DTNB) and galanthamine were purchased from Sigma (St. Louis, MO, USA). Buffer and other chemicals were of analytical grade. Acetylcholinesterase and butyrylcholinesterase inhibiting activities were measured by a slightly modified spectrophotometric method [17]. Acetylthiocholine iodide and butyrylthiocholine chloride were used as substrates to assay acetylcholinesterase and butyrylcholinesterase, respectively. 5, 5′-Dithiobis [2-nitrobenzoic-acid] (DTNB) was used for the measurement of cholinesterase activity. 140 μL of (100 mM) sodium phosphate buffer (pH = 8.0), 10 μL of DTNB, 20 μL of test compound solution and 20 μL of acetylcholinesterase or butyrylcholinesterase solution were mixed and incubated for 15 min (25°C). The reaction was then initiated by the addition of 10 μL acetylthiocholine or butyrylthiocholine, respectively. The hydrolysis of acetylthiocholine and butyrylthiocholine was monitored by the formation of the yellow 5-thio-2-nitrobenzoate anion as the result of the reaction of DTNB with thiocholine, released by the enzymatic hydrolysis of acetylthiocholine and butyrylthiocholine, respectively, at a wavelength of 412 nm (15 min). Test compounds and control were dissolved in EtOH. All the reactions were performed in triplicate in 96-well micro plates and monitored in a Spectra Max 340 (Molecular Devices, USA) spectrometer. Estimation of IC 50 values: The concentrations of test compounds which inhibited the hydrolysis of substrates (acetylthiocholine and butyrylthiocholine) by 50% (IC 50 ) were determined by monitoring the effect of increasing concentrations of these compounds in the assays on the inhibition values. The IC50 values were then calculated using the EZ-Fit Enzyme Kinetics program (Perrella Scientific Inc., Amherst, USA).

Declarations

Acknowledgements

Provision of research facility at the premier research center, the H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi is highly acknowledged.

Authors’ Affiliations

(1)
Department of Applied Chemistry, Government College University Faisalabad
(2)
International Centre for Chemical and Biological Sciences, HEJ Research Institute of Chemistry, University of Karachi
(3)
Department of Botany, Government College University Faisalabad
(4)
Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University
(5)
Department of Chemistry, University of Karachi

References

  1. Quinn DM: Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states. Chem Rev. 1987, 87: 955-979. 10.1021/cr00081a005.View ArticleGoogle Scholar
  2. Perry EK, Perry RH, Smith CJ, Dick DJ: Nicotinic receptor abnormalities in Alzheimer’s and Parkinson’s diseases. J Neurol Neurosurg Psychiatry. 1987, 50: 806-809. 10.1136/jnnp.50.6.806.View ArticleGoogle Scholar
  3. Khan SB, Haq AU, Perveen S, Afza N, Malik A, Nawaz SA, Shah MR, Choudhary MI: Butyrylcholinesterase inhibitory guaianolides from Amberboa ramosa. Arch Pharm Res. 2005, 28: 172-10.1007/BF02977710.View ArticleGoogle Scholar
  4. Akhtar N, Malik A, Afza N, Badar Y: Cycloartane-type triterpenes from amberboa ramosa. J Nat Prod. 1993, 56: 295-10.1021/np50092a019.View ArticleGoogle Scholar
  5. Meyer BN, Ferrigni NR, Putnam JE, Jacobsen LB, Nichols DE, McLaughlin JL: Brine shrimp: a convential general bioassay for active plant constituents. Planta Med. 1982, 45: 31-34. 10.1055/s-2007-971236.View ArticleGoogle Scholar
  6. Ibrahim M, Imran M, Ali B, Malik A, Rehmani FS: A secondary metabolite amberin from Amberboa ramosa. J Asian Nat Prod Res. 2012, 14: 281-285. 10.1080/10286020.2011.647503.View ArticleGoogle Scholar
  7. Ibrahim M, Khan R, Malik A: Two new guaianolides from Amberboa ramosa. Nat Prod Commun. 2010, 5: 1865-1868.Google Scholar
  8. Khan SB, Haq AU, Perveen S, Afza N, Malik A, Nawaz SA, Shah MR, Choudhary MI: Tyrosinase-inhibitory long-chain esters from Amberboa ramosa. Chem Pharm Bull. 2005, 53: 86-89. 10.1248/cpb.53.86.View ArticleGoogle Scholar
  9. Harrison DA, Kulshrestha DA: Chemical constituents of Amberboa ramosa. Fitoterapia. 1984, 55: 189-Google Scholar
  10. Menichini F, Benedetto RD, Monache FD: A triterpene epoxide and a guaianolide from Ptilostemmon gnaphaloides. Phytochemistry. 1996, 41: 1377-10.1016/0031-9422(95)00748-2.View ArticleGoogle Scholar
  11. Marco JA, Sanz JF, Albianh R, Rustaryan R, Habibi Z: Bisabolene derivatives and sesquiterpene lactones from Cousinia species. Phytochemistry. 1993, 32: 395-10.1016/S0031-9422(00)95002-7.View ArticleGoogle Scholar
  12. Seto M, Miyase T, Fukushima S: Sesquiterpene Lactones from Ixeris dentata NAKAI. Chem Pharm Bull. 1989, 34: 4170-View ArticleGoogle Scholar
  13. Youssef DTA: Sesquiterpene lactones of Centaurea scoparia. Phytochemistry. 1998, 49: 1733-1737. 10.1016/S0031-9422(98)00257-X.View ArticleGoogle Scholar
  14. Zdero C, Bohlmann F, Muller M: Sesquiterpene lactones and other constituents from Eriocephalus species. Phytochemistry. 1987, 26: 2763-2775. 10.1016/S0031-9422(00)83588-8.View ArticleGoogle Scholar
  15. Zdero C, Bohlmann F: Glaucolides, fulvenoguaianolides and other sesquiterpene lactones from Pentzia species. Phytochemistry. 1990, 29: 189-194. 10.1016/0031-9422(90)89035-8.View ArticleGoogle Scholar
  16. Khan SB, Afza N, Malik A, Haq AU, Ahmed Z: Structure determination of ramosine, a guaianolide, by NMR spectroscopy. Magn Reson Chem. 2004, 42: 1063-10.1002/mrc.1461.View ArticleGoogle Scholar
  17. Ellman GL, Courtney KD, Andres V, Featherstone RM: A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961, 7: 88-95. 10.1016/0006-2952(61)90145-9.View ArticleGoogle Scholar

Copyright

© Ibrahim et al.; licensee Chemistry Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.